Literature DB >> 19660858

Urinary trypsin inhibitor suppresses migration of malignant mesothelioma.

Takahiro Yaguchi1, Masakazu Muramoto, Takashi Nakano, Tomoyuki Nishizaki.   

Abstract

Urinary trypsin inhibitor (UTI), an inhibitor of urokinase plasminogen activator relevant to proteolytic processing from the inactive into the active form of platelet-derived growth factor-D (PDGF-D) to activate PDGF-betabeta receptor (PDGF-betabetaR), inhibited fetal bovine serum-stimulated migration of human malignant mesothelioma, with the extent varying among the cell types. The more effective inhibition was found in NCIH-2052 and -2452 cells, with the higher expression of PDGF-betabetaR. The results of the present study suggest that UTI suppresses malignant mesothelioma cell migration by neutralizing active dimer of PDGF-D (PDGF-DD)/PDGF-betabetaR-mediated signal transduction. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660858     DOI: 10.1016/j.canlet.2009.07.003

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines.

Authors:  Ombretta Melaiu; Calogerina Catalano; Chiara De Santi; Monica Cipollini; Gisella Figlioli; Lucia Pellè; Elisa Barone; Monica Evangelista; Alice Guazzelli; Laura Boldrini; Elisa Sensi; Alessandra Bonotti; Rudy Foddis; Alfonso Cristaudo; Luciano Mutti; Gabriella Fontanini; Federica Gemignani; Stefano Landi
Journal:  Genes Cancer       Date:  2017-01

2.  TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma.

Authors:  Wenliang Tan; Xuan Luo; Wenda Li; Jinyi Zhong; Jun Cao; Sicong Zhu; Xianqing Chen; Rui Zhou; Changzhen Shang; Yajin Chen
Journal:  EBioMedicine       Date:  2018-12-26       Impact factor: 8.143

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.